化疗药物联合过氧化物酶体增殖物激活受体(PPAR)的配体能够协同抑制肺细胞癌及卵巢癌细胞。
Chemotherapy given in combination with ligands for the peroxisome proliferator-activated receptor - (PPAR) synergistically inhibits the growth of lung and ovarian cancer cell lines.
其他一些药物包括H - 2受体阻断剂(雷尼替丁或法莫替丁)，可以抑制胃酸的分泌减少胃内容物。
Other pharmacologic agents include the H2-receptor blockers (ranitidine or famotidine), which inhibit gastric acid production and decrease gastric volume.
作为天然核苷受体的竞争性抑制剂，糖环部分化学改造的核苷类似物在过去的几十年中得到了深入的研究。
As competitive inhibitors of natural nucleoside receptors, sugar-modified nucleoside analogues have been well studied in the past few decades.
应用推荐